Nanosonics Past Earnings Performance

Past criteria checks 2/6

Nanosonics has been growing earnings at an average annual rate of 8.3%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 15.3% per year. Nanosonics's return on equity is 7.1%, and it has net margins of 7.6%.

Key information

8.3%

Earnings growth rate

8.1%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate15.3%
Return on equity7.1%
Net Margin7.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nanosonics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:NNCS.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24170139333
31 Mar 24167149132
31 Dec 23164168832
30 Sep 23165188731
30 Jun 23166208529
31 Mar 23154158127
31 Dec 22141107725
30 Sep 2213177324
30 Jun 2212046822
31 Mar 2212076421
31 Dec 21121116020
30 Sep 21112105719
30 Jun 2110395417
31 Mar 219975117
31 Dec 209564916
30 Sep 209784816
30 Jun 20100104816
31 Mar 2096114714
31 Dec 1992124613
30 Sep 1988134212
30 Jun 1984143811
31 Mar 1978123611
31 Dec 1871113411
30 Sep 186683310
30 Jun 186163310
31 Mar 186163110
31 Dec 176162910
30 Sep 1764162810
30 Jun 176826289
31 Mar 176526269
31 Dec 166325258
30 Sep 165313258
30 Jun 16430257
31 Mar 1633-5257
31 Dec 1523-10246
30 Sep 1523-8215
30 Jun 1522-5185
31 Mar 1524-2174
31 Dec 14262163
30 Sep 14240162
30 Jun 1421-3171
31 Mar 1421-3151

Quality Earnings: NNCS.F has high quality earnings.

Growing Profit Margin: NNCS.F's current net profit margins (7.6%) are lower than last year (12%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NNCS.F's earnings have grown by 8.3% per year over the past 5 years.

Accelerating Growth: NNCS.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: NNCS.F had negative earnings growth (-34.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (15%).


Return on Equity

High ROE: NNCS.F's Return on Equity (7.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 13:58
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nanosonics Limited is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Josh KannourakisBarrenjoey Markets Pty Limited
John HesterBell Potter